The value of contrast enhanced spectral mammography (CESM) in the assessment of lobular breast cancer by Roslyn Stanton (7169339) et al.
The Value of Contrast Enhanced Spectral 
Mammography (CESM) in the Assessment                          
of Lobular Breast Cancer 
 
Stanton, Roslyn1 ; Photiou, Dana1 ; Jethwa, Ketan1 ; Chen, Yan2; Whisker, Lisa1 ; Tennant, Sarah1 
1Nottingham Breast Institute; 2AVRC, Loughborough University 
Results  
Flow Chart to show the clinical pathway of CESM 
patients with lobular tumours 
T-test comparing CESM with MRI sizing (a)  
and CESM with pathology sizing (b) 
a-There was a non-significant difference between size at CESM 
(mean=56.53mm) and at MRI (mean=56.14mm). 
b-There was a non-significant difference between size at CESM 
(mean=29.95mm) and at final pathology (mean=27.25mm). 
  
Discussion 
In our small, retrospectively reviewed cohort , the lack of consistency between lobular breast cancer at core biopsy and the final 
pathology is interesting. If we are to advise further imaging, the pre-operative tumour assessment must be accurate. The classification 
and consistency of reporting lobular subtype at core biopsy is a challenge recognised by pathologists. 
 
Conclusion 
The patients included in this series are a highly-selected group, presenting symptomatically.  However, we have observed no 
significant difference in sizing of lesions with CESM vs MRI and /or final pathology.  In patients with lobular tumours, CESM can be 
considered a useful alternative to MRI. 
Case 1 Case 2 
* EUSOBI Mammography: an update of the EUSOBI recommendations on information for women. Sardanelli, F., Fallenberg, E.M., Clauser, P. et al. Insights Imaging (2017) 8: 11.  
Methods 
Patients with carcinoma reported as lobular at core biopsy 
or on final histology, who underwent CESM between 
December 2013 and December 2017, were identified 
(either pure lobular or lobular features).  A 2-sample t-test 
(assuming equal variances) was used to compare reported 
tumour size at CESM to size at MRI and / or size at final 
pathology. 
Background  
Lobular tumours are known to be more difficult to size accurately by 
conventional imaging (ultrasound and FFDM) and are more likely to be 
multifocal or bilateral than other subtypes.  NICE CG80 advises 
consideration of MRI for accurate staging of lobular cancers if planning 
breast conserving surgery.   
CESM compares favourably to MRI in terms of sensitivity, specificity and 
tumour sizing*.  Is this equally applicable to tumours of lobular subtype? 
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